{"ok":true,"trend":{"id":86921,"platform":"news","region":"global","key":"platform trials are rewriting the rules of evidence. regulators haven’t caught up.","title":"Platform Trials Are Rewriting the Rules of Evidence. Regulators Haven’t Caught Up.","url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNUGVMNGNoMnRUQlp5MG11WWRMYWpVM0JPaHJ0NHgxMnFQaTNJWmhVbk1nMWMyRWUyX05lVVZ4bmlRYmcwT1pkZVFrNk4xZGNMTVNZU1M2Zmp5S0tDN0hyWktadm9tU05fRDlwd0lGdVV4X2xsWmR0VV9fNEtpNzVFRndneHRQU3JJSGR3ZTY0UThjSmhkempLbDBSNnBuSVBfajlGYmdIWXZSQjlDa3c1VFd5ckEyMmdSMjRmaDVvWkZUV3Qy?oc=5","first_seen":"2026-09-27T08:34:45.653224Z","last_seen":"2026-09-27T14:02:47.866610Z","last_rank":37,"peak_rank":37,"last_volume":null,"peak_volume":0,"seen_count":5,"score":23.53,"category_hint":"medicine","section":"health","category":"medicine","summary":"Platform trials, which test multiple treatments simultaneously against a shared control group, are transforming how clinical evidence is generated, especially in emergencies like pandemics. Regulators have been slower to update their frameworks to evaluate evidence from these adaptive, multi-arm designs. The debate centers on whether existing approval standards can accommodate faster, more flexible trial methods without compromising patient safety or scientific rigor.","why":"Growing use of platform trials in drug development is prompting debate over whether regulatory frameworks need urgent modernization.","tone":"neutral","entities":["platform trials","drug regulators"],"summarized_at":"2026-09-27T08:36:44.982878Z","meta":{"via":"scan","lang":"en","term":"clinical trial","source":"The Clinical Trial Vanguard","generic":0.1,"published":"Sun, 27 Sep 2026 07:28:50 GMT"},"nw":0.62,"promo":0.02,"kind":"news_event","importance":1.73,"hidden":false,"hide_reason":null,"judged_at":"2026-09-27T08:34:46.183909Z","title_en":"Platform Trials Are Rewriting the Rules of Evidence. Regulators Haven't Caught Up.","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-09-27T08:34:45.653224Z","rank":37,"volume":null},{"captured_at":"2026-09-27T09:56:46.513038Z","rank":37,"volume":null},{"captured_at":"2026-09-27T11:18:45.470325Z","rank":37,"volume":null},{"captured_at":"2026-09-27T12:40:46.043478Z","rank":37,"volume":null},{"captured_at":"2026-09-27T14:02:47.866610Z","rank":37,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNUGVMNGNoMnRUQlp5MG11WWRMYWpVM0JPaHJ0NHgxMnFQaTNJWmhVbk1nMWMyRWUyX05lVVZ4bmlRYmcwT1pkZVFrNk4xZGNMTVNZU1M2Zmp5S0tDN0hyWktadm9tU05fRDlwd0lGdVV4X2xsWmR0VV9fNEtpNzVFRndneHRQU3JJSGR3ZTY0UThjSmhkempLbDBSNnBuSVBfajlGYmdIWXZSQjlDa3c1VFd5ckEyMmdSMjRmaDVvWkZUV3Qy?oc=5","author":"The Clinical Trial Vanguard","title":"Platform Trials Are Rewriting the Rules of Evidence. Regulators Haven’t Caught Up.","snippet":null,"posted_at":"2026-09-27T07:28:56Z","likes":null}],"elsewhere":[],"window":"7d"}}